DE10193322D2 - Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates - Google Patents

Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates

Info

Publication number
DE10193322D2
DE10193322D2 DE10193322T DE10193322T DE10193322D2 DE 10193322 D2 DE10193322 D2 DE 10193322D2 DE 10193322 T DE10193322 T DE 10193322T DE 10193322 T DE10193322 T DE 10193322T DE 10193322 D2 DE10193322 D2 DE 10193322D2
Authority
DE
Germany
Prior art keywords
diseases
treatment
proton pump
pump inhibitors
musculoskeletal system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10193322T
Other languages
English (en)
Inventor
Wilhelm Aicher
Steffen Gay
Michael George
Otto Mueller
Thomas Pap
Wolfgang Parak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eberhard Karls Universitaet Tuebingen
Universitaetsklinikum Tuebingen
Original Assignee
Eberhard Karls Universitaet Tuebingen
Universitaetsklinikum Tuebingen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eberhard Karls Universitaet Tuebingen, Universitaetsklinikum Tuebingen filed Critical Eberhard Karls Universitaet Tuebingen
Priority to DE10193322T priority Critical patent/DE10193322D2/de
Application granted granted Critical
Publication of DE10193322D2 publication Critical patent/DE10193322D2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
DE10193322T 2000-08-11 2001-08-09 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates Expired - Fee Related DE10193322D2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10193322T DE10193322D2 (de) 2000-08-11 2001-08-09 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040052A DE10040052A1 (de) 2000-08-11 2000-08-11 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Entzündungen, insbesondere von Erkrankungen des Bewegungsapparates
PCT/DE2001/003179 WO2002013796A2 (de) 2000-08-11 2001-08-09 Verwendung von protonenpumpen-hemmern zur behandlung von erkrankungen des bewegungsapparates
DE10193322T DE10193322D2 (de) 2000-08-11 2001-08-09 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates

Publications (1)

Publication Number Publication Date
DE10193322D2 true DE10193322D2 (de) 2003-08-21

Family

ID=7652636

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10040052A Ceased DE10040052A1 (de) 2000-08-11 2000-08-11 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Entzündungen, insbesondere von Erkrankungen des Bewegungsapparates
DE10193322T Expired - Fee Related DE10193322D2 (de) 2000-08-11 2001-08-09 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10040052A Ceased DE10040052A1 (de) 2000-08-11 2000-08-11 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Entzündungen, insbesondere von Erkrankungen des Bewegungsapparates

Country Status (3)

Country Link
AU (1) AU2001291604A1 (de)
DE (2) DE10040052A1 (de)
WO (1) WO2002013796A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070027189A1 (en) * 2003-09-18 2007-02-01 Altana Pharma Ag Use of known active ingredients as radical scavengers
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
EP1779848A1 (de) * 2005-10-28 2007-05-02 Nikem Research S.R.L. V-atpase Inhibitoren zur Behandlung von Entzündungserkrankungen und Autoimmunerkrankungen
US9056096B2 (en) 2010-06-04 2015-06-16 Kao Corporation Hyaluronic acid decomposition-promoting factor and inhibitor thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU886738D0 (en) * 1987-10-30 1990-02-28 Haessle Ab Process for the preparation of pharmaceutical compositions against osteoporosis containing 2-pyridinyl-methyl-(sulfinyl or thio)-benzimidazoles
JPH01203325A (ja) * 1988-02-08 1989-08-16 Takeda Chem Ind Ltd 骨粗鬆症予防治療剤
SE8903529D0 (sv) * 1989-10-24 1989-10-24 M Hersloef Medical use
SG49853A1 (en) * 1993-08-16 2001-07-24 Novartis Ag Novel macrolides and the use thereof
US5763480A (en) * 1994-02-14 1998-06-09 The Jewish Hospital Of St. Louis Inhibitors of cell-medicated disorders
US6010852A (en) * 1997-02-27 2000-01-04 Incyte Pharmaceuticals, Inc. Human proton atpase subunit
DE19828068C2 (de) * 1998-06-24 2003-12-18 Peter Dietsch Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
AUPQ051099A0 (en) * 1999-05-24 1999-06-17 Tachas, George Dr Novel products and processes in treatment and/or prophylaxis

Also Published As

Publication number Publication date
AU2001291604A1 (en) 2002-02-25
DE10040052A1 (de) 2002-03-07
WO2002013796A2 (de) 2002-02-21
WO2002013796A3 (de) 2002-09-12

Similar Documents

Publication Publication Date Title
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60105295D1 (de) Chinazolinderivate zur behandlung von tumoren
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE429922T1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE296628T1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE602004019576D1 (de) Zur behandlung von schmerzen geeignete piperazine
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
ATE418552T1 (de) Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee